The goals of the workshop were twofold: Give NIST researchers an industry perspective and evaluate the CHIPS Act Metrology R&D program industry relevance to plan to future projects. This guest editorial provides a brief overview of the February 2024 workshop and its outcomes.
No takes yet. Share an insight, caveat, or question.
F. Beaudoin (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: